235 related articles for article (PubMed ID: 20176801)
1. Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion.
Huang X; Bai X; Cao Y; Wu J; Huang M; Tang D; Tao S; Zhu T; Liu Y; Yang Y; Zhou X; Zhao Y; Wu M; Wei J; Wang D; Xu G; Wang S; Ma D; Zhou J
J Exp Med; 2010 Mar; 207(3):505-20. PubMed ID: 20176801
[TBL] [Abstract][Full Text] [Related]
2. Significance of TIM-3 expression by CD4
Shariati S; Ghods A; Zohouri M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Mol Immunol; 2020 Dec; 128():47-54. PubMed ID: 33068833
[TBL] [Abstract][Full Text] [Related]
3. Tim-3 expression is increased on peripheral T cells from diffuse large B cell lymphoma.
Xiao T; Zhang L; Chen L; Liu G; Feng Z; Gao L
Tumour Biol; 2014 Aug; 35(8):7951-6. PubMed ID: 24833097
[TBL] [Abstract][Full Text] [Related]
4. Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3
Zhang T; Ren T; Song Z; Zhao J; Jiao L; Zhang Z; He J; Liu X; Qiu L; Li L; Zhou S; Meng B; Zhai Q; Ren X; Qian Z; Wang X; Zhang H
J Immunol Res; 2020; 2020():6968595. PubMed ID: 33178839
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis.
Idali F; Wahlström J; Dahlberg B; Khademi M; Olsson T; Eklund A; Grunewald J
Respir Res; 2009 May; 10(1):42. PubMed ID: 19480659
[TBL] [Abstract][Full Text] [Related]
6. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells.
Golden-Mason L; Palmer BE; Kassam N; Townshend-Bulson L; Livingston S; McMahon BJ; Castelblanco N; Kuchroo V; Gretch DR; Rosen HR
J Virol; 2009 Sep; 83(18):9122-30. PubMed ID: 19587053
[TBL] [Abstract][Full Text] [Related]
7. TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.
Tomkowicz B; Walsh E; Cotty A; Verona R; Sabins N; Kaplan F; Santulli-Marotto S; Chin CN; Mooney J; Lingham RB; Naso M; McCabe T
PLoS One; 2015; 10(10):e0140694. PubMed ID: 26492563
[TBL] [Abstract][Full Text] [Related]
8. Antigen-independent induction of Tim-3 expression on human T cells by the common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway.
Mujib S; Jones RB; Lo C; Aidarus N; Clayton K; Sakhdari A; Benko E; Kovacs C; Ostrowski MA
J Immunol; 2012 Apr; 188(8):3745-56. PubMed ID: 22422881
[TBL] [Abstract][Full Text] [Related]
9. Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques.
Fujita T; Burwitz BJ; Chew GM; Reed JS; Pathak R; Seger E; Clayton KL; Rini JM; Ostrowski MA; Ishii N; Kuroda MJ; Hansen SG; Sacha JB; Ndhlovu LC
J Immunol; 2014 Dec; 193(11):5576-83. PubMed ID: 25348621
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Tim-3 as a therapeutic target in prostate cancer.
Piao YR; Jin ZH; Yuan KC; Jin XS
Tumour Biol; 2014 Nov; 35(11):11409-14. PubMed ID: 25119597
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Tim-3 Expression by Antigen-Dependent and -Independent Factors on T Cells from Patients with Chronic Hepatitis B Virus Infection.
Dong J; Yang XF; Wang LX; Wei X; Wang AH; Hao CQ; Shen HJ; Huang CX; Zhang Y; Lian JQ
Front Cell Infect Microbiol; 2017; 7():98. PubMed ID: 28401068
[TBL] [Abstract][Full Text] [Related]
12. Emerging immune checkpoints for cancer therapy.
Li X; Hu W; Zheng X; Zhang C; Du P; Zheng Z; Yang Y; Wu J; Ji M; Jiang J; Wu C
Acta Oncol; 2015 Nov; 54(10):1706-13. PubMed ID: 26361073
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Tim-3 as a therapeutic target in prostate cancer.
Piao Y; Jin X
Tumour Biol; 2017 Jul; 39(7):1010428317716628. PubMed ID: 28681697
[TBL] [Abstract][Full Text] [Related]
14. A Deficit of CEACAM-1-Expressing T Lymphocytes Supports Inflammation in Primary Progressive Multiple Sclerosis.
Piancone F; Saresella M; Marventano I; La Rosa F; Caputo D; Mendozzi L; Rovaris M; Clerici M
J Immunol; 2019 Jul; 203(1):76-83. PubMed ID: 31142599
[TBL] [Abstract][Full Text] [Related]
15. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
[TBL] [Abstract][Full Text] [Related]
16. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
17. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
[TBL] [Abstract][Full Text] [Related]
18. Activation of mitogen activated protein kinase-Erk kinase (MEK) increases T cell immunoglobulin mucin domain-3 (TIM-3) transcription in human T lymphocytes and a human mast cell line.
Yoon SJ; Lee MJ; Shin DC; Kim JS; Chwae YJ; Kwon MH; Kim K; Park S
Mol Immunol; 2011 Sep; 48(15-16):1778-83. PubMed ID: 21621846
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients.
Zhang Y; Cai P; Li L; Shi L; Chang P; Liang T; Yang Q; Liu Y; Wang L; Hu L
Int Immunopharmacol; 2017 Feb; 43():210-218. PubMed ID: 28038383
[TBL] [Abstract][Full Text] [Related]
20. Tim-3-expressing macrophages are functionally suppressed and expanded in oral squamous cell carcinoma due to virus-induced Gal-9 expression.
Dong J; Cheng L; Zhao M; Pan X; Feng Z; Wang D
Tumour Biol; 2017 May; 39(5):1010428317701651. PubMed ID: 28466780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
